Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9595 |
High Similarity |
NPD4380 |
Phase 2 |
0.9388 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9346 |
High Similarity |
NPD7075 |
Discontinued |
0.9304 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9221 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9211 |
High Similarity |
NPD6801 |
Discontinued |
0.915 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.915 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9114 |
High Similarity |
NPD6166 |
Phase 2 |
0.9114 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9114 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8968 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8961 |
High Similarity |
NPD1934 |
Approved |
0.8912 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8912 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8851 |
High Similarity |
NPD1549 |
Phase 2 |
0.8834 |
High Similarity |
NPD6797 |
Phase 2 |
0.878 |
High Similarity |
NPD7251 |
Discontinued |
0.8774 |
High Similarity |
NPD7411 |
Suspended |
0.8758 |
High Similarity |
NPD5403 |
Approved |
0.8727 |
High Similarity |
NPD7808 |
Phase 3 |
0.8726 |
High Similarity |
NPD3817 |
Phase 2 |
0.8716 |
High Similarity |
NPD2796 |
Approved |
0.8712 |
High Similarity |
NPD7054 |
Approved |
0.8693 |
High Similarity |
NPD1512 |
Approved |
0.8684 |
High Similarity |
NPD6799 |
Approved |
0.8662 |
High Similarity |
NPD2801 |
Approved |
0.8659 |
High Similarity |
NPD7074 |
Phase 3 |
0.8659 |
High Similarity |
NPD7472 |
Approved |
0.8649 |
High Similarity |
NPD1510 |
Phase 2 |
0.8627 |
High Similarity |
NPD5401 |
Approved |
0.8614 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8608 |
High Similarity |
NPD5402 |
Approved |
0.8571 |
High Similarity |
NPD6959 |
Discontinued |
0.8562 |
High Similarity |
NPD1511 |
Approved |
0.8553 |
High Similarity |
NPD3882 |
Suspended |
0.8544 |
High Similarity |
NPD7819 |
Suspended |
0.8537 |
High Similarity |
NPD3818 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8438 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8378 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8274 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD1607 |
Approved |
0.821 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8155 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8136 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8072 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8065 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8011 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7937 |
Intermediate Similarity |
NPD920 |
Approved |
0.7921 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7921 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7908 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7904 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7892 |
Intermediate Similarity |
NPD919 |
Approved |
0.7885 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7834 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7806 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7799 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7733 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7714 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7706 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7705 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7705 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7595 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7581 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD943 |
Approved |
0.7547 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6099 |
Approved |
0.753 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6535 |
Approved |
0.743 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7419 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7403 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7349 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7306 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7306 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD37 |
Approved |
0.7278 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7249 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7229 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7195 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7191 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7188 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7178
|
Intermediate Similarity |
NPD2654 |
Approved |